menu search

Catalyst pharmaceuticals to participate at the 2023 cantor global healthcare conference

CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst pharmaceuticals, Inc. ("Catalyst") (Nas...

September 18, 2023, 8:03 am

Is spdr s&p pharmaceuticals etf (xph) a strong etf right now?

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P pharmaceuticals ETF (XPH) prov...

September 18, 2023, 7:32 am

Triana biomedicines to present at ubs biotechnology private company virtual symposium

LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmac...

September 18, 2023, 7:30 am

Nrx pharmaceuticals to present at the sidoti virtual small cap conference

RADNOR, Pa. , Sept. 18, 2023 /PRNewswire/ -- NRx pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx ...

September 18, 2023, 6:46 am

Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against infinity, shift4, and comerica and encourages investors to contact the firm

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...

September 18, 2023, 1:00 am

Johnson & johnson: kenvue spin-off unlikely to drive market-beating returns

Johnson & Johnson had spun off Kenvue, its consumer health division, to boost growth in its more profitable ph...

September 18, 2023, 12:58 am

Rosen, trusted investor counsel, encourages infinity pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – infi

NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity ...

September 17, 2023, 8:49 pm

Activist elliott makes inroads at catalent to build value. here's what could happen next

Elliott recently entered a cooperation agreement with Catalent. This could pave the way for some major changes at the ...

September 16, 2023, 8:35 am

Ixj: healthcare dashboard for september

The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharma...

September 16, 2023, 8:26 am

Actinium pharmaceuticals trickling down through 2023: are they flying under the radar?

Actinium is making radiolabeled antibodies for use in hematologic cancers. Previously reported phase 3 trial results give a strong indicator of succes...

September 15, 2023, 7:02 pm

Abbvie vs. astrazeneca: battle of the pharmaceutical behemoths

Currently, the S&P 500 and many sectors are outperforming the healthcare sector, presenting an opportunity to explore assets within this sector during...

September 15, 2023, 1:02 pm

Here's why rocket pharmaceuticals (rckt) rises 53.8% in a week

Rocket Pharmaceucticals (RCKT) soars 53.8% in a week on news of alignment with the FDA for the mid-stage study of RP-A501, an investigational gene the...

September 15, 2023, 12:01 pm

Rayzebio stock opens with a big gain, to push valuation up to $1.4 billion

Investors cheered RayBio Inc. as it debuted on Wall Street, as the California-based radiopharmaceutical...

September 15, 2023, 11:48 am

Global biosensors market to reach us$ 48.49 billion by 2031, expanding at a cagr of 7.2%: tmr report

Increasing government investments in healthcare and pharmaceutical industries, rising prevalence of car...

September 15, 2023, 11:09 am

Better growth stock: recursion pharmaceuticals vs. crispr therapeutics

The timing of upcoming catalysts is a key consideration when comparing biotechs. Recursion pharmaceutical...

September 15, 2023, 10:07 am

Regeneron's pricing deal with federal government may have ‘far-reaching consequences,' analysts say

Regeneron pharmaceuticals Inc.'s REGN, +0.74% agreement with the federal government to limit the list p...

September 15, 2023, 8:40 am

Why crinetics pharmaceuticals stock soared this week

Crinetics pharmaceuticals announced positive late-stage trial data for its acromegaly drug this week. I...

September 15, 2023, 8:37 am

Rayzebio to go public at $1b market valuation

RayzeBio Inc shares are expected to begin trading on the Nasdaq after Friday's open as the radiopharmaceutical...

September 15, 2023, 8:36 am

Why is moleculin biotech (mbrx) stock is moving today?

Moleculin Biotech (NASDAQ: MBRX ) stock is on the move Friday after the clinical-stage pharmaceutical ...

September 15, 2023, 8:24 am


Search within

Pages Search Results: